MegaPro Biomedical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - MegaPro Biomedical Co Ltd

Watchlist Manager

Watchlist

Price: 14.05 TWD 2.55% Market Closed

Market Cap: NT$1.1B

M	MegaPro Biomedical Co Ltd TPEX:6827	TW
H	Hung Chou Fiber Ind Co Ltd TWSE:1413	TW
	Jungheinrich AG OTC:JGHAF	DE
	XLSMART Telecom Sejahtera Tbk PT F:E5F	ID
W	Well Chip Group Bhd KLSE:WELLCHIP	MY
A	Arif Habib Ltd KAR:AHL	PK
M	Mandarin Hotel PCL SET:MANRIN	TH
L	Lemon Sistemi SpA MIL:LS	IT
A	Arnoldo Mondadori Editore SpA DUS:MDD	IT
	MISC Bhd KLSE:MISC	MY
M	Moltiply Group SpA F:MNL	IT
	Fortune Mate Indonesia Tbk PT IDX:FMII	ID
D	Dongwoon Anatech Co Ltd KOSDAQ:094170	KR
H	Hosiden Corp OTC:HOIEF	JP
L	Laboratorios Richmond SACIF BCBA:RICH	AR

Profitability Summary

MegaPro Biomedical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-859,984%

Low Net Margin

Negative 3Y Average Net Margin

-775,009%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-669,461%

Negative ROE

-51%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-100%

Declining ROIC

-50% > -79%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.